TREVENA (TRVN) Alert: Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of Trevena, Inc.; Investors Encouraged to Contact Firm

SAN DIEGO, March 15, 2017 /PRNewswire/ -- Shareholder Rights Law Firm Johnson & Weaver, LLP has commenced an investigation of Trevena, Inc. (NASDAQ: TRVN) concerning possible violations of federal securities laws.Trevena is a biopharmaceutical company that develops various therapies to benefit patients and healthcare providers confronting serious medical conditions.

On February 21, 2017, Trevena disclosed that its painkiller drug oliceridine beat a placebo in two Phase 3 trials but slightly underperformed morphine.  On the news, Trevena stock fell 40% on February 21, 2017.

If you are a Trevena shareholder and are interested in learning more about the investigation or your legal rights and remedies, please contact Jim Baker ([email protected]) by email or phone at 619-814-4471. If emailing, please include a phone number.

About Johnson & Weaver, LLP:

Johnson & Weaver, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit http://www.johnsonandweaver.com. Attorney advertising. Past results do not guarantee future outcomes.

Contact:

Johnson & Weaver, LLP
Jim Baker, 619-814-4471
[email protected]

SOURCE Johnson & Weaver, LLP

Related Links

http://johnsonandweaver.com